Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 601 - 650 of 4862 results
- Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
- Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury.
- Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger.
- 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.
- Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
- Comparison of cilostazol and clopidogrel after successful coronary stenting.
- Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH).
- Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
- Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats.
- Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.
- Percutaneous endovascular treatment for chronic limb ischemia.
- The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
- YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
- Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney.
- Target-directed proteolysis at the ribosome.
- Characterization of a monoclonal antibody that antagonizes the function of human endostatin.
- Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes.
- Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation.
- Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.
- PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion.
- Oral sildenafil improves primary pulmonary hypertension refractory to epoprostenol.
- Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition.
- A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
- Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells.
- Direct, pleiotropic protective effect of cyclosporin A against simulated ischemia-induced injury in isolated cardiomyocytes.
- Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart.
- Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells.
- Protein kinase C-zeta inhibition exerts cardioprotective effects in ischemia-reperfusion injury.
- Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production.
- Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
- BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
- Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.
- Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule.
- Calmodulin kinase II inhibition protects against structural heart disease.
- Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
- Thrombosis modulates arterial drug distribution for drug-eluting stents.
- 2004 American College of Cardiology/American Heart Association guidelines for the management of patients with ST-elevation myocardial infarction: implications for emergency department practice.
- In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker.
- Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.
- Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats.
- The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly.
- Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.
- 3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.
- 9-hydroxyazafluorenes and their use in thrombin inhibitors.
- Druggability indices for protein targets derived from NMR-based screening data.
- High-throughput lipophilicity measurement with immobilized artificial membranes.
- A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty.
- Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase.
- Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis.
- Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >